Aranesp Related Clinical Trials
An Evaluation of Aranesp® in Subjects With Anaemic Chronic Kidney Disease (CKD) [Completed]
A Dose Finding Study of KRN321(Darbepoetin Alfa) for the Treatment of Anemia in Subjects With Solid Tumor [Completed]
Darbepoetin Alfa (Aranesp) Following Allogeneic Stem Cell Transplantation [Completed]
Study of Aranesp to Treat Anemia in Prostate Cancer Patients. [Completed]
Evaluation of Iron Supplementation During Darbepoetin Alfa Treatment in Prophylaxis of Severe Anaemia Chemo-Induced [Terminated]
Study to Evaluate Effectiveness of Aranesp® [Completed]
Aranesp® Monthly Preference Study - 2 [Completed]
A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy [Completed]
Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer [Active, not recruiting]
Hematologic Response of Epoetin Alfa (PROCRIT) Versus Darbepoetin Alfa (ARANESP) in Chemotherapy Induced Anemia [Completed]
Study to Develop a Screening Tool for Functional Capacity in Anemic Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Darbepoetin Alfa [Completed]
Treatment for Subjects With Chronic Kidney Disease Receiving Haemodialysis [Completed]
Study to Assess Darbepoetin Alfa in Subjects With Chronic Kidney Disease [Completed]
Efficacy Study: Darbepoetin Alfa for the Treatment of Anemia in Patients With Chronic Kidney Disease [Completed]
A Study to Assess Symptom Burden in Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Aranesp® [Completed]
Chemotherapy Related Anemia [Completed]
Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate Cancer [Active, not recruiting]
Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies [Completed]
Study of Transplant Related Anemia Treated With Aranesp® (STRATA) [Completed]
A Study Comparing Two Different PROCRIT® Doses to a Dose of ARANESP® in Anemic Cancer Patients Receiving Chemotherapy [Terminated]
An Exploratory Sub-Study for the RED-HFâ„¢ (Reduction of Events With Darbepoetin Alfa in Heart Failure) Trial [Terminated]
Study Evaluating Darbepoetin Alfa in Subjects With Chronic Kidney Disease (CKD) Receiving Dialysis [Completed]
Evaluating Aranesp® for the Treatment of Anemia in African-American Subjects With Chronic Renal Failure (CRF) Receiving Hemodialysis [Completed]
A Study to Evaluate the Effectiveness of Aranesp® for Cancer Patients With Anemia [Completed]
Evaluating Aranesp® in Subjects With End Stage Renal Disease onChronic Hemodialysis [Completed]
Darbepoetin Alfa Treatment of Anemia in Hemodialysis Subjects [Completed]
A Double-Blind Study of KRN321 for the Treatment of Anemia in Cancer Patients [Completed]
Flexibility: A Study to Assess the Impact of Darbepoetin Alfa in Subjects withNon-Myeloid Malignancies With Anemia Due to Chemotherapy [Completed]
A Study of Darbepoetin Alfa in Patients With Myelodysplastic Syndrome (MDS) [Active, not recruiting]
Aranesp and Neulasta in Patients With Sarcoma Receiving Adriamycin and Ifosfamide [Suspended]
Phase 2 Study of Darbepoetin Alfa Extended Dosing [Completed]
A Web-Based Study of Quality of Life Benefits Associated Aranesp in Anemic Patients With Cancer. [Recruiting]
STAAR-3 Clinical Study [Completed]
STAAR-1 Clinical Study [Completed]
STAAR-2 Clinical Study [Completed]
A Study of Repeat-Dose Subcutaneous Darbepoetin Alfa in Subjects With Congestive Heart Failure and Anemia, and a Single Dose in Healthy Age- and Sex-Matched Control Subjects [Completed]
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease [Not yet recruiting]
A Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin Alfa [Completed]
Cost-Effectiveness Study of Epoetin Alfa and Darbepoetin Alfa in Adult Patients With Cancer Who Have Anemia [Recruiting]
Randomized Epo and Venofer Trial After Autologous HSCT [Recruiting]
Dose-Finding Study of Novel Erythropoiesis Stimulating Protein (NESP) for the Treatment of Anaemia in Subjects With Solid Tumours Receiving Multicycle Chemotherapy [Completed]
Anemia in Patients With a Non-Myeloid Malignancy [Completed]
Treatment for Subjects With Chronic Kidney Disease (CKD) Not Receiving Dialysis [Completed]
Treatment for Anemic Subjects With Non-Myeloid Malignancies Receiving Chemotherapy [Completed]
COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.
A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With a Non-Myeloid Malignancy
Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer [Active, not recruiting]
Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer [Active, not recruiting]
Darbepoetin Alfa Administered Once Every 4 Weeks in the Treatment of Subjects With Anemia of Cancer [Completed]
The Darbepoetin Alfa for Ischemic Surgical Complications (DISC) Dose Finding Trial [Recruiting]
Study for Subjects With Chronic Kidney Disease(CKD) Not Receiving Dialysis [Completed]
Darbepoetin Alfa in Treating Anemia in Patients With Cancer Who Are Receiving Chemotherapy [No longer recruiting]
AIM 3: Anemia and Iron Management With Every 3 Week Dosing in Anemic Subjects With Nonmyeloid Malignancies [Completed]
Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer [Recruiting]
Evaluation of Retinal Changes in Systemic Darbepoetin Alpha Treatment in Patients With Diabetes Mellitus [Recruiting]
Darbepoetin Alfa in Treating Anemia in Patients With Non-Myeloid Cancer Who Are Not Receiving Chemotherapy [Recruiting]
Darbepoetin Alfa With or Without IV Iron [Not yet recruiting]
A Study of Darbepoetin Alfa in Anemic Subjects With Low Risk Myelodysplastic Syndrome [Completed]
Fludarabine and Darbepoetin Alfa in Treating Older Patients With Chronic Lymphocytic Leukemia [Recruiting]
Study of Darbepoetin Alfa for the Treatment of Anemia of Cancer [No longer recruiting]
A Study of Darbepoetin Alfa in Anemic Subjects Not Receiving Chemotherapy Who Have Completed the 20010103 Study [No longer recruiting]
Extension From Weekly to Once Every Other Week Darbepoetin Alfa Administration in Subjects With Chronic Kidney Disease Receiving Dialysis [No longer recruiting]
Impact of Darbepoetin Alfa on Exercise Tolerance and Left Ventricular Structure in Subjects With Symptomatic Congestive Heart Failure (CHF) and Anemia [Completed]
R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-Cell Lymphoma [Recruiting]
STIMULATE Study: Aaemia Correction and HRQoL Outcomes in Elderly CKD Patients [Recruiting]
Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy [Recruiting]
Evaluating Treatment of Anemia in Subjects With Non-Myeloid MalignanciesReceiving Multicycle Chemotherapy [Completed]
Darbepoetin Treatment of Anemia in Children With Chronic Renal Failure [Recruiting]
Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to Chemotherapy [Completed]
Treatment for Patients Suffering From Anemia Due to Chemotherapy [Completed]
Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to Chemotherapy [Completed]
Treatment for Patients With Non-Myeloid Malignancies Receiving Chemotherapy [Completed]
Darbepoetin Administration to Preterm Infants [Recruiting]
Safety of Darbepoetin Alfa Treatment in Patients With Severe Traumatic Brain Injury [Recruiting]
Darbepoetin Alfa in Patients With "Poor Prognosis" Germ Cell Tumor Treated With High-Dose Chemotherapy (HD-VIP) [Recruiting]
Combination Chemotherapy With or Without Darbepoetin Alfa in Treating Women With Stage III Breast Cancer [Recruiting]
A Study Comparing Subcutaneous Mircera and Darbepoetin Alfa for the Maintenance Treatment of Anemia in Kidney Transplant Recipients. [Recruiting]
Subcutaneous (SC) Darbepoetin Alfa in Subjects With Symptomatic Congestive Heart Failure (CHF) & Anemia [No longer recruiting]
Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies [Completed]
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis. [Recruiting]
Azacitidine, Darbepoetin Alfa, and G-CSF in Treating Patients With Myelodysplastic Syndromes [Recruiting]
Darbepoetin Alpha in Myelodysplastic Syndromes (MDS) [Recruiting]
A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis. [Recruiting]
The Effect of Darbepoetin Upon Rehabilitation for Colorectal Cancer Surgery [Completed]
Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy [Completed]
Will Radiation/Chemotherapy Treatment of Cervical Cancer Work Better With Medication That May Improve Anemia? [Active, not recruiting]
ACCELERATE: Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Pegfilgrastim and Darbepoetin Alfa Support for the Treatment of Women With Breast Cancer [Recruiting]
Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Heart Failure and Anemia [Completed]
Dosing and Outcomes Study of Erythropoietic Stimulating Therapies (D.O.S.E. Registry) [Enrolling by invitation]
Study for the Treatment of Anemia in Patients With Non-Myeloid Malignancies Receiving Multicycle Chemotherapy. [Completed]
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients. [Active, not recruiting]
Study of Erythropoietin to Treat Anemia Complicating Chronic Obstructive Pulmonary Disease [Not yet recruiting]
Erythropoietin (EPO) and Granulocyte-Colony Stimulating Factor (G-CSF) for Low-Risk Myelodysplastic Syndromes (MDS) [Recruiting]
A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis. [Recruiting]
Safety and Efficacy Study of Hematide Injection in Chronic Renal Failure Subjects. [Recruiting]
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients. [Recruiting]
Audit of the Effect of Changing From Intravenous to Subcutaneous Administration of Erythropoeisis Stimulating Agents in Haemodialysis Patients [Not yet recruiting]
Rituximab and Combination Chemotherapy Combined With Yttrium Y 90 Ibritumomab Tiuxetan in Treating Older Patients With Previously Untreated B-Cell Lymphoma [Recruiting]
Safety & Efficacy Study of Hematideâ„¢ for the Correction of Anemia in Patients With Chronic Renal Failure (CRF) Not on Dialysis and Not on Erythropoiesis Stimulating Agent (ESA) Treatment [Recruiting]
Safety and Efficacy of Hematideâ„¢ for the Correction of Anemia in Patients With Chronic Renal Failure (PEARL 2) [Recruiting]
|
